COSCIENS Biopharma (CSCI) 6-K/A Current report (foreign) (amended)

Exhibit 23.1

	Raymond Chabot Grant Thornton LLP
	Suite 2000 National Bank Tower
	600 De La Gauchetière Street West Montréal, Quebec
	H3B 4L8
Consent of Independent Registered
Public Accounting Firm	T 514-878-2691

We have issued our report dated April 29, 2024 with respect to the consolidated financial statements of Ceapro Inc. included in the Form 6-K of Aeterna Zentaris Inc. filed on May 14, 2024. We consent to the incorporation by reference of the said report in the Registration Statements of Aeterna Zentaris Inc. on Form F-3 (File No. 333- 254680) and on Forms S-8 (File No. 333-224737, File No. 333-210561 and File No. 333-200834).

/s/ Raymond Chabot Grant Thornton LLP

Montréal, Canada

May 14, 2024

Member of Grant Thornton International Ltd rcgt.com